PMID: 25764669Mar 15, 2015Paper

Development of antiviral treatments for chronic hepatitis C

Nihon rinsho. Japanese journal of clinical medicine
Hidetaka Fujinaiga, Kazuhiko Koike

Abstract

The antiviral therapy for chronic hepatitis C has been developed since HCV was discovered in 1989. As for the patients with genotype 1, sustained virological response rate by interferon monotherapy was less than 20% in 1990's; the rate has been improved today to 85% by direct-acting antivirals. The prevention of development of liver cirrhosis and hepatocellular carcinoma will be expected.

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.